Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2023). Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 200(1), 85–92. https://doi.org/10.1007/s10549-023-06957-5
Authors:
Claire Sathe
Melissa K Accordino
David DeStephano
Mansi Shah
Jason D Wright
Dawn L Hershman
Affiliated Authors:
Claire Sathe
Melissa K Accordino
David DeStephano
Mansi Shah
Jason D Wright
Dawn L Hershman
Columbia Affiliation:
Subjects:
Breast Neoplasms (MeSH)
Leukopenia (MeSH)
Author Keywords:
cdk4/6 inhibitors
metastatic breast cancer
novel targeted agents
treatment disparities
elink
Publication Type:
Article
Unique ID:
10.1007/s10549-023-06957-5
PMID:
37157005
DOI:
10.1007/s10549-023-06957-5
Journal:
Breast Cancer Research and Treatment
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: